Principal Investigator
COVID-19 continues to pose a significant health risk in tropical regions of Australia, where high-risk populations are often concentrated. This project aims to establish an immunology research group within James Cook University's College of Medicine and Dentistry to explore the T-cell immune responses to COVID-19 in these tropical populations. Leveraging a cost-effective, high-throughput RT-qPCR technique developed at JCU, we will assess and track the immunogenicity of SARS-CoV-2 peptide epitopes in donors over several months. The study will optimize this method for fresh blood samples, gather preliminary data on immune variability, and inform the design and budgeting of a larger-scale future investigation.
27 Jan 2025 - 26 Jan 2026
N/A
T cell;SARS-CoV2;RTqPCR;ELIspot
Far North Queensland Hospital Foundation
4995
Daniel Browne;Chanika Alahakoon;Kate Miller
